NYVEPRIA FDA approval date

The FDA approved NYVEPRIA on 10 Jun 2020.

FDA approval date
10 Jun 2020

Drug identity has not yet been verified against registry records

Also recorded as PEGFILGRASTIM-APGF

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-06-10DayNYVEPRIAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761111", "applicant_as_listed_by_fda": "HOSPIRA INC", "brand_names": ["NYVEPRIA"], "active_ingredients": ["PEGFILGRASTIM-APGF"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200610", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026